DE60111732D1 - Verfahren zur herstellung von substituierten benzimidazolverbindungen - Google Patents

Verfahren zur herstellung von substituierten benzimidazolverbindungen

Info

Publication number
DE60111732D1
DE60111732D1 DE60111732T DE60111732T DE60111732D1 DE 60111732 D1 DE60111732 D1 DE 60111732D1 DE 60111732 T DE60111732 T DE 60111732T DE 60111732 T DE60111732 T DE 60111732T DE 60111732 D1 DE60111732 D1 DE 60111732D1
Authority
DE
Germany
Prior art keywords
substituted benzimidazole
benzimidazole compounds
producing substituted
compounds
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60111732T
Other languages
English (en)
Other versions
DE60111732T2 (de
Inventor
Stephen Freeman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DE60111732D1 publication Critical patent/DE60111732D1/de
Publication of DE60111732T2 publication Critical patent/DE60111732T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60111732T 2000-04-11 2001-04-10 Verfahren zur herstellung von substituierten benzimidazolverbindungen Expired - Lifetime DE60111732T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0008939 2000-04-11
GBGB0008939.1A GB0008939D0 (en) 2000-04-11 2000-04-11 Process for preparing substituted benzimidazole compounds
PCT/EP2001/004080 WO2001077083A1 (en) 2000-04-11 2001-04-10 Process for preparing substituted benzimidazole compounds

Publications (2)

Publication Number Publication Date
DE60111732D1 true DE60111732D1 (de) 2005-08-04
DE60111732T2 DE60111732T2 (de) 2006-05-04

Family

ID=9889715

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60111732T Expired - Lifetime DE60111732T2 (de) 2000-04-11 2001-04-10 Verfahren zur herstellung von substituierten benzimidazolverbindungen

Country Status (9)

Country Link
US (4) US7101994B2 (de)
EP (2) EP1272473B1 (de)
JP (2) JP4841793B2 (de)
AT (1) ATE298746T1 (de)
AU (1) AU2001256272A1 (de)
DE (1) DE60111732T2 (de)
ES (1) ES2243488T3 (de)
GB (1) GB0008939D0 (de)
WO (1) WO2001077083A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000034248A1 (en) 1998-12-04 2000-06-15 Neurosearch A/S New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
NZ537301A (en) * 2002-06-07 2006-06-30 Cortical Pty Ltd Therapeutic molecules and methods-1
CN101448506A (zh) * 2005-12-02 2009-06-03 拜尔健康护理有限责任公司 通过抑制有丝分裂酶激酶治疗癌症的吡咯并三嗪衍生物
US7655004B2 (en) 2007-02-15 2010-02-02 Ethicon Endo-Surgery, Inc. Electroporation ablation apparatus, system, and method
US8888792B2 (en) 2008-07-14 2014-11-18 Ethicon Endo-Surgery, Inc. Tissue apposition clip application devices and methods
US8157834B2 (en) 2008-11-25 2012-04-17 Ethicon Endo-Surgery, Inc. Rotational coupling device for surgical instrument with flexible actuators
US20110098704A1 (en) 2009-10-28 2011-04-28 Ethicon Endo-Surgery, Inc. Electrical ablation devices
US8546344B2 (en) 2010-10-28 2013-10-01 Viropharma Incorporated Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl)-1H-benzimidazole
US9254169B2 (en) 2011-02-28 2016-02-09 Ethicon Endo-Surgery, Inc. Electrical ablation devices and methods
US9233241B2 (en) 2011-02-28 2016-01-12 Ethicon Endo-Surgery, Inc. Electrical ablation devices and methods
CN102952104A (zh) * 2011-08-17 2013-03-06 黑龙江省松花江药业有限公司 一种呋喃类化合物
US9427255B2 (en) 2012-05-14 2016-08-30 Ethicon Endo-Surgery, Inc. Apparatus for introducing a steerable camera assembly into a patient
US9545290B2 (en) 2012-07-30 2017-01-17 Ethicon Endo-Surgery, Inc. Needle probe guide
US10314649B2 (en) 2012-08-02 2019-06-11 Ethicon Endo-Surgery, Inc. Flexible expandable electrode and method of intraluminal delivery of pulsed power
US9277957B2 (en) 2012-08-15 2016-03-08 Ethicon Endo-Surgery, Inc. Electrosurgical devices and methods
US10098527B2 (en) 2013-02-27 2018-10-16 Ethidcon Endo-Surgery, Inc. System for performing a minimally invasive surgical procedure
AU2023361470A1 (en) 2022-10-12 2024-09-19 Takeda Pharmaceutical Company Limited Method of preparing maribavir

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3839743A1 (de) 1988-11-25 1990-05-31 Hoechst Ag Verfahren zur herstellung von benzimidazolonen
JP2955358B2 (ja) * 1989-06-09 1999-10-04 ファルマシア・アンド・アップジョン・カンパニー 中枢神経系活性を有する複素環系アミン
US5248672A (en) 1990-11-01 1993-09-28 The Regents Of The University Of Michigan Polysubstituted benzimidazole nucleosides as antiviral agents
GB9205071D0 (en) 1992-03-09 1992-04-22 Wellcome Found Therapeutic nucleosides
GB9413724D0 (en) * 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides
BR9508826A (pt) 1994-09-09 1997-09-30 Wellcome Found Análogos de nucleosídeo antivirais contendo uma base de benzimidazol substituída ligada a um anel carboxílico
WO1997007125A1 (en) 1995-08-18 1997-02-27 The Regents Of The University Of Michigan 5'-substituted-ribofuranosyl benzimidazoles as antiviral agents
GB9600142D0 (en) 1996-01-05 1996-03-06 Wellcome Found Chemical compounds
GB9600143D0 (en) 1996-01-05 1996-03-06 Wellcome Found Therapeutic compounds
TR199801431T2 (xx) 1996-01-23 1998-10-21 The Regents Of The University Of Michigan Antiviral aktif maddeler olarak de�i�tirilmi� benzimidazol n�kleosidler.
JP2001512453A (ja) 1997-02-13 2001-08-21 グラックス グループ リミテッド ベンゾイミダゾール誘導体
BR9810745A (pt) 1997-06-10 2001-03-13 Glaxo Group Ltd Derivados de benzimidazol
PL338454A1 (en) 1997-07-30 2000-11-06 Univ Michigan Lixofuranosilbenzimidazoles as antiviral agents
GB9807354D0 (en) 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
GB9807355D0 (en) 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
GB9815696D0 (en) * 1998-07-20 1998-09-16 Pfizer Ltd Heterocyclics

Also Published As

Publication number Publication date
ATE298746T1 (de) 2005-07-15
US20050261211A1 (en) 2005-11-24
US7101994B2 (en) 2006-09-05
DE60111732T2 (de) 2006-05-04
GB0008939D0 (en) 2000-05-31
ES2243488T3 (es) 2005-12-01
JP5192061B2 (ja) 2013-05-08
JP2003530385A (ja) 2003-10-14
WO2001077083A1 (en) 2001-10-18
US7858773B2 (en) 2010-12-28
EP1584620A1 (de) 2005-10-12
JP4841793B2 (ja) 2011-12-21
JP2011173906A (ja) 2011-09-08
US20030191127A1 (en) 2003-10-09
US20080188668A1 (en) 2008-08-07
US7375235B2 (en) 2008-05-20
EP1272473B1 (de) 2005-06-29
AU2001256272A1 (en) 2001-10-23
US20090187015A1 (en) 2009-07-23
EP1272473A1 (de) 2003-01-08
US7514568B2 (en) 2009-04-07

Similar Documents

Publication Publication Date Title
ATE298746T1 (de) Verfahren zur herstellung von substituierten benzimidazolverbindungen
DE502004009142D1 (de) Verfahren zur herstellung substituierter 3-aryl-butyl-aminverbindungen
DE60234952D1 (de) VERFAHREN ZUR HERSTELLUNG VON HEXAHYDROFUROc2,3-BÜFURAN-3-OL
ATE414077T1 (de) Verfahren zur herstellung von 1-ä(benzimidazol-1- yl)chinolin-8-ylüpiperidin-4-ylaminderivaten
DE60105732D1 (de) Verfahren zur Herstellung von 3-l-Menthoxypropan-1,2-diol
ATE286011T1 (de) Verfahren zur herstellung von 1-octen
DE60206996D1 (de) Verfahren zur Herstellung von 3-l-Menthoxypropan-1,2-diol
DE502005000428D1 (de) Verfahren zur Herstellung von 1,2-Diaminocyclohexan-Platin(II)-Komplexen
ATE537173T1 (de) Verfahren zur herstellung von cucurbiturilen
ATE287882T1 (de) Verfahren zur herstellung von imidazolverbindungen
ATE506351T1 (de) Verfahren zur herstellung von 10,11-dihydro-10- oxo-5h-dibenzoäb,füazepin-5-carboxamid
DE60103416D1 (de) Verfahren zur herstellung von 2-alkoxy-6-trifluoromethyl-n-([1,2,4]triazolo[1,5-c]pyrimidin-2-yl)benzolsulfonamiden
DE60210778D1 (de) Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen
ATE424892T1 (de) Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
ATE281434T1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
DE60216931D1 (de) Verfahren zur herstellung von bisphenol-a
DE602004004677D1 (de) Verfahren zur herstellung substituierter 5-amino-pyrazolo-ä4,3-eü-1,2,4-triazoloä1,5-cüpyrimidine
ATE332905T1 (de) Verfahren zur herstellung von acylphosphinoxiden
DE60006111D1 (de) Aluminosiloxanverbindungen und verfahren zu ihrer herstellung
ATE374757T1 (de) Verfahren zur herstellung von (1,4,5)- oxadiazepinderivaten
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
DE602004023534D1 (de) Verfahren zur herstellung von optisch aktivem 2-alkylcystein, derivate davon und herstellungsverfahren
DE50203388D1 (de) Verbessertes verfahren zur herstellung von bisphosphiten
ATE394398T1 (de) Verfahren zur herstellung von imidazo(1,2- a)pyridin-3-acetamiden
ATE425143T1 (de) Verfahren zur herstellung von indolen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition